Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Role of Angiotensin-Converting Enzyme 2 in Covid-19 Induced Lung Injury Publisher Pubmed



Torabi S1 ; Bahreini F2, 3 ; Rezaei N3, 4, 5, 6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran
  3. 3. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Networ(USERN), Tehran, Iran
  4. 4. Research Center for Immunodeficiencies (RCID), Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Research Center for Immunodeficiencies, Children’s Medical Center Hospital, Dr. Qarib St, Keshavarz Blvd, Tehran, 14194, Iran

Source: Acta Biomedica Published:2020


Abstract

The novel coronavirus disease (COVID-19) has affected people around the world both physically and psychologically. As result, developing a coronavirus-specific vaccine and/or therapeutics is now a top priority for public health agencies. Since our findings of COVID-19 are relatively new, the current knowledge about the molecular mechanism involved in pathogenicity and virulence of the novel coronavirus is not advanced. Understanding angiotensin-converting enzyme 2 (ACE2), the receptor for the coronavirus, is significantly important. To better illustrate the role of ACE2 in the severity of COVID-19 and the impact of currently used drugs on this receptor, this paper briefly reviews newly published articles in this regard. (www.actabiomedica.it). © Mattioli 1885.
Related Docs
View other Related Docs
1. Exploration of the Epidemiological and Emotional Impact of Quarantine and Isolation During the Covid-19 Pandemic, Advances in Experimental Medicine and Biology (2021)
2. Health Care Policies and Covid-19 Prevalence: Is There Any Association?, International Journal of Health Services (2022)
3. A Systematic Review of Pregnant Women With Covid-19 and Their Neonates, Archives of Gynecology and Obstetrics (2021)
4. Computed Tomography Scan in Covid-19: A Systematic Review and Meta-Analysis, Polish Journal of Radiology (2022)
5. The Immune System As a Target for Therapy of Sars-Cov-2: A Systematic Review of the Current Immunotherapies for Covid-19, Life Sciences (2020)
6. Altered Immunoemotional Regulatory System in Covid-19: From the Origins to Opportunities, Journal of Neuroimmunology (2021)
7. Neurologic Manifestations of Covid-19, Advances in Experimental Medicine and Biology (2021)
8. Interferon Therapy in Patients With Sars, Mers, and Covid-19: A Systematic Review and Meta-Analysis of Clinical Studies, European Journal of Pharmacology (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (58)
Seyyed Farshad Allameh (2)
Other Related Docs
9. Primary Immunodeficiency Diseases in Covid-19 Pandemic: A Predisposing or Protective Factor?, American Journal of the Medical Sciences (2020)
10. Cytokine Release Syndrome: Inhibition of Pro-Inflammatory Cytokines As a Solution for Reducing Covid-19 Mortality, European Cytokine Network (2020)
11. Dysregulation of the Immune Response in Coronavirus Disease 2019, Cell Biology International (2021)
12. Microfluidic Devices for Detection of Rna Viruses, Reviews in Medical Virology (2021)
13. Geriatrics and Covid-19, Advances in Experimental Medicine and Biology (2021)
14. Computational Drug Discovery and Repurposing for the Treatment of Covid-19: A Systematic Review, Bioorganic Chemistry (2021)
15. Anosmia: A Missing Link in the Neuroimmunology of Coronavirus Disease 2019 (Covid-19), Reviews in the Neurosciences (2020)
16. Angiotensin-Converting Enzyme 2 (Ace2) Receptor and Sars-Cov-2: Potential Therapeutic Targeting, European Journal of Pharmacology (2020)
17. Health and Art (Heart): Integrating Science and Art to Fight Covid-19, Advances in Experimental Medicine and Biology (2021)
18. Coronavirus: Pure Infectious Disease or Genetic Predisposition, Advances in Experimental Medicine and Biology (2021)
19. Biosensing Surfaces and Therapeutic Biomaterials for the Central Nervous System in Covid-19, Emergent Materials (2021)
20. How Prevalent Is Cancer in Confirmed Cases With Coronaviruses and Severe Acute Respiratory Syndromes?, Advances in Experimental Medicine and Biology (2021)
21. Nutrition and Immunity in Covid-19, Advances in Experimental Medicine and Biology (2021)
22. Covid-19 and Its Global Economic Impact, Advances in Experimental Medicine and Biology (2021)
23. Interdisciplinary Approaches to Covid-19, Advances in Experimental Medicine and Biology (2021)
24. Anti-Ige Monoclonal Antibodies As Potential Treatment in Covid-19, Immunopharmacology and Immunotoxicology (2021)
25. An Overview on Tumor Treating Fields (Ttfields) Technology As a New Potential Subsidiary Biophysical Treatment for Covid-19, Drug Delivery and Translational Research (2022)
26. Cytokines and Covid-19: Friends or Foes?, Human Vaccines and Immunotherapeutics (2020)
27. Immunotherapy for Sars-Cov-2: Potential Opportunities, Expert Opinion on Biological Therapy (2020)
28. Introduction on Coronavirus Disease (Covid-19) Pandemic: The Global Challenge, Advances in Experimental Medicine and Biology (2021)
29. Prevention of Covid-19: Preventive Strategies for General Population, Healthcare Setting, and Various Professions, Advances in Experimental Medicine and Biology (2021)
30. Regenerative Medicine in Covid-19 Treatment: Real Opportunities and Range of Promises, Stem Cell Reviews and Reports (2021)
31. Clinical Manifestations of Covid-19, Advances in Experimental Medicine and Biology (2021)
32. A Borderless Solution Is Needed for a Borderless Complexity, Like Covid-19, the Universal Invader, Advances in Experimental Medicine and Biology (2021)
33. Clinical and Laboratory Predictors of Severity, Criticality, and Mortality in Covid-19: A Multisystem Disease, Advances in Experimental Medicine and Biology (2021)
34. Covid-19 in Patients With Cancer, Advances in Experimental Medicine and Biology (2021)
35. How Covid-19 Has Globalized: Unknown Origin, Rapid Transmission, and the Immune System Nourishment, Advances in Experimental Medicine and Biology (2021)
36. Covid-19 and Medical Biotechnology, Avicenna Journal of Medical Biotechnology (2020)
37. Sars-Cov-2: From the Pathogenesis to Potential Anti-Viral Treatments, Biomedicine and Pharmacotherapy (2021)
38. Human Coronaviruses Sars-Cov, Mers-Cov, and Sars-Cov-2 in Children, Journal of Pediatric Nursing (2021)
39. Serological Tests for Covid-19: Potential Opportunities, Cell Biology International (2021)
40. Covid-19 Infection and Stroke Risk, Reviews in the Neurosciences (2021)
41. Cardiovascular Diseases Burden in Covid-19: Systematic Review and Meta-Analysis, American Journal of Emergency Medicine (2021)
42. Monoclonal Antibody As a Potential Anti-Covid-19, Biomedicine and Pharmacotherapy (2020)
43. Dynamic Antibody Response: A Biomarker for Covid-19, Clinical Laboratory (2021)
44. Covid-19 in a Child With Primary Antibody Deficiency, Clinical Case Reports (2021)
45. Covid-19: Transmission, Prevention, and Potential Therapeutic Opportunities, Clinica Chimica Acta (2020)
46. The Epidemiologic Aspects of Covid-19 Outbreak: Spreading Beyond Expectations, Advances in Experimental Medicine and Biology (2021)
47. Socialization During the Covid-19 Pandemic: The Role of Social and Scientific Networks During Social Distancing, Advances in Experimental Medicine and Biology (2021)
48. Central Nervous System Involvement in Covid-19, Archives of Medical Research (2020)
49. Targeted Therapy Strategies Against Sars-Cov-2 Cell Entry Mechanisms: A Systematic Review of in Vitro and in Vivo Studies, Journal of Cellular Physiology (2021)
50. Death Due to Covid-19 in a Patient With Diabetes, Epilepsy, and Gout Comorbidities, Clinical Case Reports (2020)